NCT04495712View on ClinicalTrials.gov

Antiarrhythmic Effects of Spironolactone in Patients With ICDs

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 28, 2004

Primary Completion Date

May 28, 2008

Study Completion Date

May 28, 2008

Conditions
Ventricular Arrhythmias
Interventions
DRUG

spironolactone

aldosterone blocker

DRUG

placebo

identical in appearance to spironolactone study drug

Trial Locations (1)

97239

VA Portland Health Care System, Portland, OR, Portland

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT04495712 - Antiarrhythmic Effects of Spironolactone in Patients With ICDs | Biotech Hunter | Biotech Hunter